cycloviracin b1 profile

cycloviracin B1: structure given in first source; isolated from Kibdelosporangium albatum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	132423
MeSH ID	M0208383

Synonyms (7)

Synonym
142382-45-4
bu 4224v-b1
3-(16,22-bis((2-o-methyl-beta-d-glucopyranosyl)oxy)tricosyl)-9,10,11,20,21,22-hexahydroxy-14-(20-hydroxy-14-((2-o-methyl-beta-d-glucopyranosyl)oxy)heneicosyl)-2,6,13,17,23,24-hexaoxatricyclo(17.3.1.1(8,12))tetracosane-5,16-dione
cycloviracin-b1
2,6,13,17,23,24-hexaoxatricyclo(17.3.1.1(8,12))tetracosane-5,16-dione, 3-(16,22-bis((2-o-methyl-beta-d-glucopyranosyl)oxy)tricosyl)-9,10,11,20,21,22-hexahydroxy-14-(20-hydroxy-14-((2-o-methyl-beta-d-glucopyranosyl)oxy)heneicosyl)-
cycloviracin b1
3-[16,22-bis[[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy]tricosyl]-14-[14-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy-20-hydroxyhenicosyl]-9,10,11,20,21,22-hexahydroxy-2,6,13,17,23,24-hexaoxatricyc

Research

Studies (6)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	3 (50.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.41 (24.57)
Research Supply Index	1.95 (2.92)
Research Growth Index	4.36 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

cycloviracin b1

Description